Rising Awareness about Postpartum Hemorrhage Creating Growth Spurt in the Global PPH Treatment Devices Market
Postpartum hemorrhages can occur in both natural birth as well as after a C-section, with the total blood loss being the difference. If, within 24 hours of delivery, the mother loses more than 1,000 ml of blood after a cesarean section, or more than 500 ml of blood after vaginal delivery, she will be diagnosed with an early stage of PPH. Lack of care for the patient can prove to be fatal. Doctors state that poor uterine contractions are the leading cause of postpartum hemorrhaging. With that taken into consideration, most of the products in the global PPH treatment devices market will aim towards healing the uterine condition.
The global PPH treatment devices market was valued at US$604.4 mn in 2014. Exhibiting a CAGR of 4.90% between 2015 and 2023, this market could possibly reach US$926.1 mn before the end of 2023. The key players in this market are ZOEX NIASG, Bactiguard AB, 3rd Stone Design, Inc., PATH, C. R. Bard, Inc., Cook Medical, Inc., Teleflex Incorporated, and Utah Medical Products, Inc.
The WHO and its Stance on PPH Treatment Devices
According to the World Health Organization, postpartum hemorrhaging is the leading reason for the rising maternal mortality rates. Most women who are diagnosed with it die within 24 hours of childbirth. The good news is that most PPH deaths can be avoided through timely medical intervention and the use of appropriate prophylactic uterotonics when the patient is in stage three of labor. The WHO has also stated that most cases of PPH-related deaths are found in developing economies, citing multiple reasons ranging from a lack of attention to unavailability of modern devices and treatments.
Scientists Find Certain Drugs can Increase Chances of PPH
One of the greater discoveries in modern medicine regarding PPH treatment devices is the link between consumption of antidepressants during pregnancy and postpartum hemorrhaging. Scientists from Canada have found out, along with teams from other locations, that consuming SNRI antidepressants in the final month of pregnancy can increase the changes of suffering from PPH. The effect of this find is the increase in awareness among medical experts regarding the use and avoidance of certain drugs during pregnancy in order to reduce the chances of complications.
High PPH Prevalence in Developing Economies Boosts Global PPH Treatment Devices Market
As mentioned earlier, developing economies show a high rate of PPH-related deaths. Optimistically speaking, the global PPH treatment devices market is currently undergoing a higher-than-normal growth rate, as these regions are showing major improvements in the healthcare industry. These improvements are related to infrastructure as well as awareness, two factors that can certainly increase the chances of avoiding PPH deaths.
Browse Research Release: http://www.transparencymarketresearch.com/pressrelease/global-postpartum-hemorrhage-treatment-devices-market.htm
Another attribute of the global PPH treatment devices market is the level of collaboration that major players are employing to increase their reach. These companies are tying up with healthcare organizations for long-term benefits to provide the most innovative options to the healthcare industry. It becomes a win-win situation for patients as well as companies, as treatment methods can get more affordable while the companies increase their level of market penetration.